Next Article in Journal
Evaluation of an Online Survey for Pertussis Case Investigations in Regional Queensland: Impacts on Workload and Disease Trends
Next Article in Special Issue
Prevalence of Antimicrobial and Colistin Resistance in Enterobacterales in Healthy Pigs in Ghana Before and After Farmer Education
Previous Article in Journal
Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors
Previous Article in Special Issue
Enterobacterales and Antimicrobial Resistance in Feed, Water, and Slurry in Pig Production Farms in the Greater Accra Region of Ghana, 2024
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Operational Research Improves Compliance with Treatment Guidelines for Empirical Management of Urinary Tract Infection: A Before-and-After Study from a Primary Health Facility in Ghana

by
Elizabeth Boateng
1,2,*,
Helena Owusu
1,2,
Pruthu Thekkur
3,
George Kwesi Hedidor
4,
Oksana Corquaye
1,2,
Mercy N. A. Opare-Addo
5,
Florence Amah Nkansah
1,
Priscilla Vandyck-Sey
2,
Daniel Ankrah
1 and
Charles Nii Kwadee Ofei-Palm
1
1
Pharmacy Department, Korle Bu Teaching Hospital, Accra P.O. Box KB77, Ghana
2
Korle Bu Polyclinic/Family Medicine Department, Accra P.O. Box KB77, Ghana
3
Centre for Operational Research, International Union Against Tuberculosis and Lung Disease (The Union), 75001 Paris, France
4
World Health Organization Country Office, Accra P.O. Box MB142, Ghana
5
Department of Pharmacy Practice, Kwame Nkrumah University of Science and Technology, Kumasi P.O. Box 509, Ghana
*
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2025, 10(9), 259; https://doi.org/10.3390/tropicalmed10090259
Submission received: 9 August 2025 / Revised: 5 September 2025 / Accepted: 8 September 2025 / Published: 11 September 2025

Abstract

Compliance with standard treatment guidelines (STGs) for the empirical management of uncomplicated urinary tract infections (UTIs) ensures the rational use of antibiotics and mitigates antimicrobial resistance. Operational research (OR) at Korle Bu Polyclinic in Ghana (2022) showed suboptimal STG compliance (prescription of recommended antibiotics in the correct dose, route, frequency, and duration). Some of the recommendations from the OR, including training of medical residents, implementation of an antimicrobial stewardship team, and an audit–feedback system, were implemented. This before-and-after study compared the changes in empirical prescribing practices for patients diagnosed with uncomplicated UTIs before (October 2019–October 2021) and after (January 2023–December 2024) the OR. Of the 3717 and 3457 UTI patients in the before and after cohorts, 83% and 86% received empirical antibiotics, respectively. Among those who received empirical antibiotics, STG compliance increased from 60% to 66% (p-value < 0.001). However, STG compliance remained significantly lower among males (18%) compared to females (85%) in the after cohort, as 80% of males were prescribed antibiotics for a shorter period than the recommended 10–14 days. Moving forward, the training and audit–feedback system should emphasize longer antibiotic durations for males with UTI. Given its positive impact, the OR’s approach warrants replication for other disease conditions.

1. Introduction

Urinary tract infections (UTIs) are the second most common infectious disease after upper respiratory tract infections [1]. It is estimated that about 50% of women and 12% of men develop UTIs at least once in their lifetime [2]. Globally, an estimated 150 million people develop UTIs each year, resulting in more than six billion dollars of direct healthcare expenditures [2]. In 2019, nearly 240,000 patients died from complications related to UTI worldwide [3]. Though about 80% of UTIs are uncomplicated, without structural or functional abnormalities in the urinary tract, if not treated promptly, they can progress to life-threatening consequences such as complicated UTIs, pyelonephritis, and sepsis [4].
Global guidelines recommend empirical antibiotics for the management of suspected uncomplicated UTIs as they help in the early resolution of symptoms and prevent complications compared to placebo or non-steroidal anti-inflammatory drugs [5,6]. Empirical antibiotics form the mainstay of management of uncomplicated UTIs in lower-and-middle-income countries (LMIC) with poor access to definitive diagnosis with culture and drug susceptibility testing (CDST) [7,8]. Thus, countries are advised to develop standard treatment guidelines (STGs) with specific guidance on empirical antibiotics based on the antibiogram of uropathogens, costs, efficacy, and availability of the antibiotics in the country [7,8,9].
Globally, most countries have STGs for uncomplicated UTIs [1,10]. Previous studies from the United States, Sweden, Netherlands, China, and Lebanon have reported poor compliance with STGs on empirical antibiotics for management of uncomplicated UTIs [11,12,13,14,15,16,17,18]. Such poor compliance could lead to suboptimal management of UTIs and irrational use of antibiotics, contributing to antimicrobial resistance [19].
In Ghana, the STGs (7th Edition, 2017) recommend empirical oral ciprofloxacin or cefuroxime for 5–7 days for females and 10–14 days for males for the management of uncomplicated UTI [20]. Until 2022, there were no studies on compliance with the STGs in the management of uncomplicated UTI in primary health facilities of Ghana. Through the Structured Operational Research Training Initiative (SORT IT) [21,22], Owusu et al. [23] conducted operational research to assess compliance with the STGs in prescribing empirical antibiotics for adults diagnosed with uncomplicated UTI at the Korle Bu Polyclinic/Family Medicine Department (KBPFMD, hereafter referred to as KBP) between 2019 and 2021.
Owusu et al. [23] found that of 3717 patients with uncomplicated UTI, 83% were prescribed empirical antibiotics, of which only 60% were prescribed the drug, dose, frequency and duration in line with the STGs. This low compliance was mainly due to the prescription of empirical antibiotics for a duration not in line with the STGs, especially among male patients who required antibiotics for 10–14 days. To improve compliance with STGs in KBP, the investigators recommended instituting an audit–feedback system, exploring the reasons for poor compliance, and promoting similar efforts for assessing compliance with STGs in managing other common conditions [23]. The investigators also recommended that the Ministry of Health (MoH) revise the STGs by introducing Access group antibiotics for the empirical management of uncomplicated UTIs and consider reducing the treatment duration for male patients. However, revisions to the STGs are ongoing and will be implemented soon.
The principal investigator (PI) actively disseminated the operational research findings and recommendations to the decision-makers of the KBP using knowledge management aids developed through SORT IT [24]. Following active dissemination, some of the recommendations were partially or completely implemented at the KBP (as detailed in Section 2). However, there was a need for a formal assessment to explore whether the implementation of recommendations from the operational research had improved compliance with the STGs. Thus, we conducted an audit of empirical antibiotic use among adult patients (≥18 years) diagnosed with uncomplicated UTIs at the KBP during January 2023 to December 2024 (after cohort) to compare the proportion that was prescribed empirical antibiotics, the pattern of empirical antibiotics used across World Health Organization’s AWaRe categories, and the proportion of prescribed empirical antibiotics in line with the STGs with those found among those diagnosed during October 2019 to October 2021 (before cohort).

2. Materials and Methods

2.1. Study Design

This was a before (October 2019–October 2021) and after (January 2023–December 2024) comparison of cross-sectional assessments conducted using routinely collected electronic data of patients with uncomplicated UTI diagnosed at the KBP.

2.2. Study Setting

2.2.1. General Setting

Ghana, an LMIC, is located in West Africa, with a population of 34 million according to the World Population Prospects 2023 [25]. The country is divided into 16 administrative regions, with Greater Accra being the capital [25]. Ghana’s healthcare system operates within a three-tier structure: primary, secondary, and tertiary [26]. The healthcare system is mostly managed by the government through the National Health Insurance Scheme (NHIS). The NHIS supports outpatient services, inpatient services, laboratory investigations, and medicines for about 95% of the common diseases in Ghana [27,28].

2.2.2. Specific Setting

The KBP is the primary care arm of the Korle Bu Teaching Hospital, the largest teaching hospital in Ghana. The KBP is a 42-bed facility in the capital city of Accra and provides healthcare services to the local community and the staff of Korle Bu Teaching Hospital. The KBP offers various services, including 24-hour emergency care, eye care, radiology, pharmacy, laboratory, child immunization, and minor surgeries. About 200 outpatients visit KBP daily. Approximately 90% of outpatients are enrolled under the NHIS, significantly reducing out-of-pocket expenditures for healthcare services [28].
Management of Uncomplicated UTIs at the KBP
The diagnosis and treatment of uncomplicated UTI are supposed to align with the STGs of Ghana [20]. UTIs are suspected based on the patient’s presenting complaints and/or routine examination of mid-stream urine. Though CDST is advised in the STGs for the management of uncomplicated UTI, it is hardly ever used by the treating physicians, mainly because of cost and the non-availability of tests at the in-house laboratory. Thus, patients with suspected uncomplicated UTIs are usually treated with empirical antibiotics and antipyretic drugs on an ambulatory basis. According to the STGs, patients with suspected uncomplicated UTIs may be prescribed empirical oral antibiotics, either ciprofloxacin or cefuroxime. For adults, when empirical antibiotics are prescribed, these have to be ciprofloxacin 500 mg every 12 h for 7 days in females and 10–14 days in males or cefuroxime 250–500 mg every 12 h for 5–7 days in females and 10–14 days in males [20]. Both ciprofloxacin and cefuroxime, recommended in the STGs, are part of the essential drug list of the KBTH and are mostly available throughout the year. The pharmacy at the KBP also has several other oral antibiotics available. Individuals with complicated UTIs are usually admitted and treated with intravenous antibiotics.
Electronic Medical Records
The KBP has been using an electronic medical record (EMR) system since 2019. The socio-demographic, clinical, laboratory and pharmacy details of all the outpatients are captured in the EMRs. The socio-demographic details of outpatients are captured at the registration desk, and a unique ID is generated. The clinician enters the clinical details into the EMRs, including the provisional diagnosis according to the International Classification of Diseases-10 (ICD-10) [29]. Then, the clinician makes an electronic prescription detailing the drug (generic name), dose, frequency, and duration for each medication prescribed. The electronic prescription is accessed at the pharmacy to dispense the prescribed medicines to the patients. If some prescribed medications are unavailable, an electronic prescription is printed and issued to the patient for purchase elsewhere. In addition, all the laboratory investigation results are available as scanned copies against the patient visit.

2.2.3. Dissemination of Findings of the Operational Research Study

As mentioned earlier, Owusu et al. [23] conducted a study to assess compliance with the STGs in prescribing empirical antibiotics for uncomplicated UTIs. The PI disseminated the study findings and the recommendations to the decision-makers and key stakeholders of the KBP. The published article and the dissemination materials developed during module 4 (module on communicating research findings) of SORT IT were used for dissemination. The dissemination details are reported in Table 1.

2.2.4. Recommendations Made and Actions Taken

Following the effective dissemination of information, some of the recommendations made by Owusu et al. [23] were translated into actions. In Table 2, we have mapped the recommendations made and actions taken, as reported by the PI of the previous study.

2.3. Study Population

All adults (aged ≥ 18 years) who were diagnosed with uncomplicated UTI (with ICD-10 code of N39.0) in the outpatient department of the KBP from January 2023 to December 2024 were included in the study. Patients with complicated UTIs, those with urethral catheters, pregnant women, those with urologic abnormalities, repeat visits within 30 days of initial treatment, and inpatients were excluded from the study. Owusu et al. [23] also included a similar study population during October 2019 to October 2021.
Assuming that compliance would increase by at least 5% (60% to 65%) in the after period, with a confidence level of 95% and a power of 80%, the minimum sample size needed for the study was calculated to be 1490 outpatients. However, we included all outpatients diagnosed with uncomplicated UTI during the study period.

2.4. Data Collection, Sources, and Variables

In January 2025, the principal investigator liaised with the Information Technology (IT) unit of the KBP and downloaded the registration, OPD consultation, and pharmacy prescription details of all uncomplicated UTI outpatients (ICD-10 code of N39.0) between January 2023 and December 2024 from the EMR. Pregnant women and inpatients were excluded before downloading. These data were then screened and filtered to remove all ineligible participants (repeat visits within 30 days of initial treatment). In addition, information on prescriber details (gender and rank), routine urine examination (done/not done), and co-morbidities (diabetes and/or hypertension) were extracted manually from the EMRs by two independent researchers, since these were not part of the extracted data. Similar efforts were made by Owusu et al. [23] while extracting data for the previous operational research study and the database was directly used for analysis.

Operational Definitions

Prescribed any empirical antibiotic: All uncomplicated UTI patients who have been prescribed at least one antibiotic in their first prescription.
Prescribed empirical antibiotic drug recommended in STGs: All uncomplicated UTI patients who have been prescribed either ciprofloxacin or cefuroxime in their first prescription.
Prescribed empirical antibiotics in line with STGs: All uncomplicated UTI patients who have been prescribed either ciprofloxacin or cefuroxime in the dose, route, frequency, and duration as per the STGs.

2.5. Data Analysis

The downloaded data in Microsoft Excel format were cleaned and imported into Stata (version 16.0, Copyright 1985–2019, StataCorp LLC, College Station, TX, USA) for analysis. The socio-demographic, clinical, and prescriber characteristics were categorized and summarized using frequencies and percentages. The chi-square test was used to compare the socio-demographic, clinical, and prescriber characteristics in the before (October 2019 to October 2021) and after (January 2024 to December 2024) cohorts.
Numbers and percentages were used to describe the patients with uncomplicated UTIs prescribed an empirical antibiotic, prescribed an empirical antibiotic drug recommended in the STGs, and those prescribed empirical antibiotics in line with the STGs. The chi-square test was used to compare these percentages across the before and after cohorts. Numbers and percentages were used to describe the pattern of empirical antibiotics used across the WHO AwaRe (Access, Watch, and Reserve) categories. The chi-square test was used to compare these percentages across the before and after cohorts.
Log binomial regression was used for unadjusted analysis in the after cohort to assess the association of patient and prescriber characteristics with those “prescribed empirical antibiotics in line with the STGs”. We conducted an adjusted analysis using modified Poisson regression with all the patient and prescriber characteristics included. The prevalence ratios (PRs) and adjusted prevalence ratios (aPRs) with 95% CIs were presented as the measure of association.

3. Results

3.1. Socio-Demographic and Clinical Characteristics

In total, 3457 adults diagnosed with uncomplicated UTIs in the outpatient department of the KBP between January 2023 and December 2024 were included in the reassessment conducted “after” the operational research (after cohort). The mean age of the patients was 49.5 (19.9) years; 2483 (71.8%) were females and 2718 (78.6%) were covered under the NHIS. Of the 3457 patients, 644 (18.6%) and 1327 (38.4%) had diabetes and hypertension, respectively. The prescriber was a male for 1783 (51.6%) patients and held the rank of medical officer for 1466 (42.4%) patients (Table 3).
The socio-demographic characteristics of the “before” cohort are described in the manuscript published by Owusu et al. [23]. There was no statistically significant difference in age, sex and NHIS coverage among patients diagnosed in the before (October 2019 to October 2021) and after (January 2024 to December 2024) cohorts. There was a statistically significant difference in the distribution of hypertension (33.1% vs. 38.4%), diabetes (16.7% vs. 18.6%), and routine urine examination (69.3% vs. 67.1%) among patients included in the before and after cohorts. Similarly, there was a statistically significant difference in the distribution of prescriber characteristics (Table 3).

3.2. Prescription of Empirical Antibiotics for UTI Patients

In the after cohort of 3457 patients, 2986 (86.4%) received an empirical antibiotic. Among these, 2719 (91.1%) were prescribed antibiotics recommended in the STGs. Nearly all these 2719 patients received the correct dose, frequency, and route, as specified in the STGs. However, only 72.7% of patients received antibiotics for the recommended duration according to the STGs, with a notably low proportion among males (20%). Among the 2986 patients prescribed an empirical antibiotic, 1975 (66.1%) received treatment that met the STG recommendations for dose, route, frequency, and duration. Additionally, 10% of these patients were prescribed concurrent antibiotics (Figure 1). A corresponding description for the before cohort is provided in the manuscript by Owusu et al. [23].
Compared with the before cohort, the after cohort showed a statistically significant increase in the proportion of patients with uncomplicated UTI who were prescribed empirical antibiotics (83.0% to 86.4%, p < 0.001), the STG-recommended empirical antibiotic (88.0% to 91.1%, p < 0.001), and the recommended treatment duration (68.0% to 72.7%). The proportion of patients receiving empirical antibiotics fully compliant with the STGs also increased significantly (60.0% to 66.1%, p < 0.001), representing a 10% relative improvement (Table 4).

3.3. Distribution of Prescribed Empirical Antibiotics Across the WHO AWaRe Category

In the before cohort, 3378 empirical antibiotics were prescribed for 3073 patients (1.1 per patient), compared with 3491 empirical antibiotics prescribed for 2986 patients in the after cohort (1.2 per patient). The proportion of Access group antibiotics increased significantly from 11.2% in the before cohort to 16.5% in the after cohort (p < 0.001). Significant increases were observed in the use of Access group antibiotics such as nitrofurantoin (2.7% to 4.1%), doxycycline (2.6% to 4.5%), and metronidazole (0.2% to 2.0%). In both cohorts, cefuroxime and ciprofloxacin were the most frequently prescribed antibiotics. However, cefuroxime use declined significantly (54.2% to 42.4%), while ciprofloxacin use increased (30.7% to 35.9%) between the before and after cohorts (Table 5).

3.4. Patient and Prescriber Characteristics Associated with the Prescription of Empirical Antibiotics Not in Line with the STGs

In the after cohort, on adjusted analysis, males (aPR-5.4, 95% CI: 4.9–6.1), compared to females, had a significantly higher risk of being prescribed empirical antibiotics not as recommended in STGs. None of the other patient characteristics (age, NHIS status, presence of comorbidities, and routine urine examination) or prescriber characteristics (gender and rank) were independently associated with being prescribed empirical antibiotics not as recommended in the STGs (Table 6).

4. Discussion

This before-and-after study showed an increase in compliance with the STGs in prescribing empirical antibiotics for uncomplicated urinary tract infections in a primary health facility in Ghana, following the implementation of recommendations of an operational research by Owusu et al. [23]. There were some key programmatic changes that we noticed in the after cohort (January 2023–December 2024) compared to the before cohort (October 2019–October 2021) after the operational research was conducted. First, there was a 10% relative increase (from 60% to 66%) in compliance with the STGs. Second, there was a significant increase in the prescription of empirical antibiotics. Third, there was an increase in the prescription of the WHO Access category antibiotics. Finally, males still had a five times higher risk of being prescribed empirical antibiotics not in line with the STGs, primarily because antibiotics were not prescribed for a longer duration (10–14 days).
Antimicrobial resistance (AMR) contributes to an estimated five million annual deaths globally, with the highest burden of death in the Western Sub-Saharan African region [30]. Thus, there is an urgent need to develop and implement effective strategies for promoting the rational use of antimicrobials to tackle the emergence of AMR [31]. This study from Ghana has shown how insights from an audit through operational research can increase the rational use of antibiotics by improving compliance with the STGs for uncomplicated UTI, which is one of the top ten causes of OPD visits in the country [32]. Hence, the study justifies the WHO’s call to implement audit–feedback systems in the healthcare facilities of LMICs, as well as the utility of operational research in applying it [33].
This study has some strengths. First, we used the same inclusion criteria, data source, operational definitions, STGs, and statistical package to assess compliance with the STGs in both before and after cohorts, improving the internal validity of the comparison. Secondly, the substantial sample size provided the statistical power to accurately assess adherence to the STGs and compare it between the before and after cohorts. Thirdly, the EMR data used in the study were complete, without any missing values. Finally, we adhered to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for reporting study findings [34].
This study has some limitations. First, not having a control group limited our ability to entirely attribute the improvement in compliance with the implementation of the recommendations of the before study. However, as the time difference between the two assessments was short and no other changes were put in place to enhance service delivery in the facility, the improvement can likely be attributed to the implementation of the recommendations. Second, the prescriber and patient characteristics (hypertension and routine urine examination) were not comparable between the before and after cohorts. As the prescriber and patient characteristics were not independently associated with compliance with the STGs in both the before and after cohorts, the effect of the differences in prescriber characteristics on the compliance comparison may be negligible. Third, due to the unavailability of data, we audited the prescriptions by the treating physicians, rather than the actual drug dispensation process by the pharmacist, to describe compliance with the STGs. However, physicians only prescribe the drugs available in the facility, and the pharmacist dispenses all prescribed medications. Fourth, although the previous study recommended future audits to assess the uptake of CDST, antibiograms, and antibiotic switching when required, difficulties in integrating laboratory data prevented such exploration. Finally, given that the study was conducted in a single primary care facility functioning under a teaching hospital, its findings may not be readily generalizable to other primary care settings in the country.
Despite these limitations, the study findings have some important implications for antimicrobial stewardship in primary care settings.
First, the significant increase in empirical antibiotic prescriptions for uncomplicated UTIs in the after cohort might be due to the introduction of the “STG orientation with clinical audit” in the medical residents’ training programme, as recommended by Owusu et al. [23]. Although the STGs recommend that empirical antibiotics may be prescribed while awaiting the confirmatory diagnosis of UTI [20], poor access to free CDST services in the facility necessitates the use of empirical antibiotics for the management of uncomplicated UTI. Thus, the increase in empirical antibiotic prescriptions is appreciable given the low coverage of CDST [5,6]. However, it is essential to enhance access to CDST for the confirmatory diagnosis of UTI by expanding laboratory capacity to perform CDST and subsidizing CDST cost by incorporating it into the NHIS [20].
Second, the 10% relative increase in compliance with the STGs in the after cohort may be attributed to the implementation of the audit–feedback mechanism in the pharmacy and the introduction of STG orientation during medical residents’ training. These findings are similar to those from a tertiary hospital in Ghana, where antibiotic use was reduced and prescription practices improved following the introduction of education and feedback interventions as part of an antimicrobial stewardship programme [35]. Thus, to ensure the rational use of antibiotics and increase compliance with the STGs in Ghana, there is a need for implementing STG orientation and audit–feedback interventions through antimicrobial stewardship programmes established in health facilities [33].
Third, there was an increase in the use of the WHO Access category of antibiotics in the after cohort. This is in contrast to the STGs, as both antibiotics recommended for uncomplicated UTIs fall within the Watch category [20]. As some of the senior physicians refer to international guidelines (Up to Date, British National Formulary, Medscape, etc.) for the management of uncomplicated UTIs, they prefer using Access category drugs like nitrofurantoin, recommended in the guidelines. The recommendations of international guidelines align with the WHO’s push for using Access category antibiotics empirically [36]. Thus, the MoH of Ghana should consider including Access category antibiotics, such as nitrofurantoin, for the empirical management of uncomplicated UTIs in the next edition of Ghana’s STGs, which is currently being drafted.
Fourth, despite a decrease in non-compliance with the STGs while prescribing empirical antibiotics for males with uncomplicated UTI (from 93% to 82%), still, eight out of ten males were not prescribed empirical antibiotics in line with the STGs. This was mainly because only one in five males were prescribed antibiotics for 10–14 days, as recommended in the STGs. Similar low compliance with STGs was reported when longer treatment durations were recommended in other countries [15,18,37]. UTIs in men are considered severe, as they can cause long-lasting complications in the genitourinary tract; therefore, a longer duration of therapy is recommended [38]. Although recent studies have reported that five to seven days of empirical antibiotic treatment for males with uncomplicated UTI is effective [39,40], there is limited evidence from LMICs, including Ghana. Thus, there is a need for randomized controlled trials in Ghana to assess the effectiveness of shorter durations of empirical antibiotics for males with uncomplicated UTIs. Furthermore, there is an urgent need for targeted focus during training and audit–feedback activities to highlight the need for a longer duration of treatment for males with uncomplicated UTI.
In conclusion, this study showed how prescription audit through operational research using EMRs and implementation of recommendations improved the empirical treatment of uncomplicated UTIs in a primary care setting in Ghana. Given the availability of similar EMR systems in other facilities in Ghana, prescription audits through operational research should be extended to other sites and applied to various infectious diseases to improve STG compliance and promote rational antibiotic use. To achieve this, it is essential to strengthen the operational research capacity of antimicrobial stewardship programme personnel in health facilities through practical training initiatives, such as SORT IT [22]. Similar approaches in other LMICs could help curb irrational antibiotic use, reduce the burden of AMR, and save lives.

Author Contributions

Conceptualization, E.B., H.O., P.T., D.A., F.A.N., C.N.K.O.-P., and P.V.-S.; methodology, E.B., H.O., P.T., and G.K.H.; software, P.T.; validation, P.T., E.B., and H.O.; formal analysis, P.T. and E.B.; investigation, E.B., H.O., O.C., and M.N.A.O.-A.; resources, E.B., H.O., O.C., and C.N.K.O.-P.; data curation, E.B., P.T., and O.C.; writing—original draft preparation, E.B., H.O., and P.T.; writing—review and editing, E.B., H.O., P.T., O.C., G.K.H., M.N.A.O.-A., D.A., and F.A.N.; visualization, P.T., E.B., H.O., and G.K.H.; supervision, P.T., H.O., G.K.H., and P.V.-S.; project administration, E.B. and H.O. All authors have read and agreed to the published version of the manuscript.

Funding

This SORT IT programme was funded by TDR (Grant Number TDR.HQTDR 2422924-4.1-72863). The APC was also funded by TDR. TDR is able to conduct its work thanks to the commitment and support from a variety of funders. A full list of TDR donors is available at https://tdr.who.int/about-us/our-donors (accessed on 20 July 2025).

Institutional Review Board Statement

Ethics approval was obtained from the Korle Bu Teaching Hospital Ethics and Scientific Review Committee (KBTH-STC/IRB/000208/2024) and the Ethics advisory group of the International Union Against Tuberculosis and Lung Disease, Paris, France (19/24 dated 22 August 2024). Permission to use the data was obtained on 13 January 2025 in Accra, Ghana.

Informed Consent Statement

As we used secondary anonymized data, the issue of informed consent did not apply.

Acknowledgments

This publication was developed through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by TDR, UNICEF, UNDP, World Bank, and the WHO Special Programme for Research and Training in Tropical Diseases, hosted at the World Health Organization (WHO). This specific SORT IT programme that led to this publication included a collaboration between TDR, The Word Health Organization Ghana Country Office, and following Ghanian and International Institutions (listed in alphabetic order). International Institutions: The Centre for Operational Research of the International Union Against Tuberculosis and Lung Disease (The Union), Paris and India offices; The Institute of Tropical Medicine, Antwerp, Belgium; Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry; The National TB Control Programme of Kyrgyzstan; The Tuberculosis Research and Prevention Center NGO, Armenia. University of St Andrews Medical School, Scotland, UK. Ghana institutions; 37 Military Hospital, Ghana; Bishop Ackon Memorial Christian Eye Centre, Ghana; Council for Scientific and Industrial Research—Animal and Water Research Institutes, Ghana; Environmental Protection Authority, Ghana; Ho Teaching Hospital, Ghana; Korle-Bu Teaching Hospital, Ghana University Hospital; Kwame Nkrumah University of Science and Technology, Ghana; Department of Pharmacy Practice, Kwame Nkrumah University of Science and Technology, Ghana University of Health and Allied Sciences, Ghana. We gratefully acknowledge the contributions of all participating institutions and partners.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Tandogdu, Z.; Wagenlehner, F. Global Epidemiology of Urinary Tract Infections. Curr. Opin. Infect. Dis. 2016, 29, 73–79. [Google Scholar] [CrossRef]
  2. Foxman, B. Epidemiology of Urinary Tract Infections: Incidence, Morbidity, and Economic Costs. Am. J. Med. 2002, 113 (Suppl. 1), 5–13. [Google Scholar] [CrossRef]
  3. Zeng, Z.; Zhan, J.; Zhang, K.; Chen, H.; Cheng, S. Global, Regional, and National Burden of Urinary Tract Infections from 1990 to 2019: An Analysis of the Global Burden of Disease Study 2019. World J. Urol. 2022, 40, 755–763. [Google Scholar] [CrossRef]
  4. Antinori, S.; Pezzani, M.D. Uncomplicated and Complicated Urinary Tract Infections in Adults: The Infectious Diseases’s Specialist Perspective. In Imaging and Intervention in Urinary Tract Infections and Urosepsis; Springer: Cham, Switzerland, 2018; pp. 17–33. ISBN 978-3-319-68276-1. [Google Scholar]
  5. Ong Lopez, A.; Tan, C.; Yabon, A.; Masbang, A. Symptomatic Treatment (Using NSAIDS) versus Antibiotics in Uncomplicated Lower Urinary Tract Infection: A Meta-Analysis and Systematic Review of Randomized Controlled Trials. BMC Infect. Dis. 2021, 21, 619. [Google Scholar] [CrossRef]
  6. Falagas, M.E.; Kotsantis, I.K.; Vouloumanou, E.K.; Rafailidis, P.I. Antibiotics versus Placebo in the Treatment of Women with Uncomplicated Cystitis: A Meta-Analysis of Randomized Controlled Trials. J. Infect. 2009, 58, 91–102. [Google Scholar] [CrossRef] [PubMed]
  7. Flores-Mireles, A.L.; Walker, J.N.; Caparon, M.; Hultgren, S.J. Urinary Tract Infections: Epidemiology, Mechanisms of Infection and Treatment Options. Nat. Rev. Microbiol. 2015, 13, 269–284. [Google Scholar] [CrossRef]
  8. Gupta, K.; Hooton, T.M.; Naber, K.G.; Rn Wullt, B.; Colgan, R.; Miller, L.G.; Moran, G.J.; Nicolle, L.E.; Raz, R.; Schaeffer, A.J.; et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 2011, 52, e103–e120. [Google Scholar] [CrossRef]
  9. Wang, R.; LaSala, C. Role of Antibiotic Resistance in Urinary Tract Infection Management: A Cost-Effectiveness Analysis. Am. J. Obstet. Gynecol. 2021, 225, 550.e1–550.e10. [Google Scholar] [CrossRef]
  10. Gupta, K.; Grigoryan, L.; Trautner, B. Urinary Tract Infection. Ann. Intern. Med. 2017, 167, ITC49–ITC64. [Google Scholar] [CrossRef] [PubMed]
  11. Mulder, M.; Baan, E.; Verbon, A.; Stricker, B.; Verhamme, K. Trends of Prescribing Antimicrobial Drugs for Urinary Tract Infections in Primary Care in the Netherlands: A Population-Based Cohort Study. BMJ Open 2019, 9, e027221. [Google Scholar] [CrossRef] [PubMed]
  12. Isberg, H.K.; Hedin, K.; Melander, E.; Mölstad, S.; Beckman, A. Increased Adherence to Treatment Guidelines in Patients with Urinary Tract Infection in Primary Care: A Retrospective Study. PLoS ONE 2019, 14, e0214572. [Google Scholar] [CrossRef]
  13. Langner, J.L.; Chiang, K.F.; Stafford, R.S. Current Prescribing Practices and Guideline Concordance for the Treatment of Uncomplicated Urinary Tract Infections in Women. Am. J. Obstet. Gynecol. 2021, 225, 272.e1–272.e11. [Google Scholar] [CrossRef]
  14. Grigoryan, L.; Zoorob, R.; Wang, H.; Trautner, B.W. Low Concordance With Guidelines for Treatment of Acute Cystitis in Primary Care. Open Forum Infect. Dis. 2015, 2, ofv159. [Google Scholar] [CrossRef] [PubMed]
  15. Durkin, M.J.; Keller, M.; Butler, A.M.; Kwon, J.H.; Dubberke, E.R.; Miller, A.C.; Polgreen, P.M.; Olsen, M.A. An Assessment of Inappropriate Antibiotic Use and Guideline Adherence for Uncomplicated Urinary Tract Infections. Open Forum Infect. Dis. 2018, 5, ofy198. [Google Scholar] [CrossRef]
  16. Wong, C.; Kung, K.; Au-Doung, P.; Ip, M.; Lee, N.; Fung, A.; Wong, S. Antibiotic Resistance Rates and Physician Antibiotic Prescription Patterns of Uncomplicated Urinary Tract Infections in Southern Chinese Primary Care. PLoS ONE 2017, 12, e0177266. [Google Scholar] [CrossRef]
  17. Zhu, H.; Chen, Y.; Hang, Y.; Luo, H.; Fang, X.; Xiao, Y.; Cao, X.; Zou, S.; Hu, X.; Hu, L.; et al. Impact of Inappropriate Empirical Antibiotic Treatment on Clinical Outcomes of Urinary Tract Infections Caused by Escherichia Coli: A Retrospective Cohort Study. J. Glob. Antimicrob. Resist. 2021, 26, 148–153. [Google Scholar] [CrossRef] [PubMed]
  18. Kabbara, W.K.; Meski, M.M.; Ramadan, W.H.; Maaliki, D.S.; Salameh, P. Adherence to International Guidelines for the Treatment of Uncomplicated Urinary Tract Infections in Lebanon. Can. J. Infect. Dis. Med. Microbiol. 2018, 2018, 7404095. [Google Scholar] [CrossRef]
  19. Appaneal, H.; Shireman, T.; Lopes, V.; Mor, V.; Dosa, D.; LaPlante, K.; Caffrey, A. Poor Clinical Outcomes Associated with Suboptimal Antibiotic Treatment among Older Long-Term Care Facility Residents with Urinary Tract Infection: A Retrospective Cohort Study. BMC Geriatr. 2021, 21, 436. [Google Scholar] [CrossRef]
  20. Ministry of Health. Ghana National Drugs Programme Urinary Tract Infection. In Standard Treatment Guidelines; Ministry of Health: Accra, Ghana, 2017; pp. 401–403. ISBN 9789988257873. [Google Scholar]
  21. Zachariah, R.; Stewart, A.G.; Chakaya, J.M.; Teck, R.; Khogali, M.A.; Harries, A.D.; Seeley-Musgrave, C.; Samba, T.; Reeder, J.C. The Structured Operational Research and Training Initiative for Strengthening Health Systems to Tackle Antimicrobial Resistance and Improve Public Health in Low-and-Middle Income Countries. Int. J. Environ. Res. Public Health 2022, 19, 4582. [Google Scholar] [CrossRef]
  22. TDR SORT IT Operational Research and Training. Available online: https://tdr.who.int/activities/sort-it-operational-research-and-training (accessed on 8 December 2023).
  23. Owusu, H.; Thekkur, P.; Ashubwe-Jalemba, J.; Hedidor, G.K.; Corquaye, O.; Aggor, A.; Steele-Dadzie, A.; Ankrah, D. Compliance to Guidelines in Prescribing Empirical Antibiotics for Individuals with Uncomplicated Urinary Tract Infection in a Primary Health Facility of Ghana, 2019-2021. Int. J. Environ. Res. Public Health 2022, 19, 12413. [Google Scholar] [CrossRef]
  24. TDR Communicating Research Findings with a KISS. Available online: https://tdr.who.int/newsroom/news/item/21-06-2021-communicating-research-findings-with-a-kiss (accessed on 6 June 2023).
  25. UN. Human Population. World Population Prospect. 2023. Available online: https://data.worldbank.org/indicator/SP.PPO.TOTL?locations=GH (accessed on 24 July 2025).
  26. Assan, A.; Takian, A.; Aikins, M.; Akbarisari, A. Universal Health Coverage Necessitates a System Approach: An Analysis of Community-Based Health Planning and Services (CHPS) Initiative in Ghana. Glob. Health 2018, 14, 107. [Google Scholar] [CrossRef]
  27. NHIS–Your Access to Healthcare. Available online: http://www.nhis.gov.gh/ (accessed on 5 November 2021).
  28. Christmals, C.D.; Aidam, K. Implementation of the National Health Insurance Scheme (NHIS) in Ghana: Lessons for South Africa and Low-and Middle-Income Countries. Risk Manag. Healthc. Policy 2020, 13, 1879–1904. [Google Scholar] [CrossRef]
  29. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems: Tenth Revision. Available online: https://iris.who.int/handle/10665/42980 (accessed on 25 July 2025).
  30. Murray, C.J.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Robles Aguilar, G.; Gray, A.; Han, C.; Bisignano, C.; Rao, P.; Wool, E.; et al. Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef]
  31. Llor, C.; Bjerrum, L. Antimicrobial Resistance: Risk Associated with Antibiotic Overuse and Initiatives to Reduce the Problem. Ther. Adv. Drug Saf. 2014, 5, 229. [Google Scholar] [CrossRef]
  32. Donkor, E.S.; Horlortu, P.Z.; Dayie, N.T.K.D.; Obeng-Nkrumah, N.; Labi, A.K. Community Acquired Urinary Tract Infections among Adults in Accra, Ghana. Infect. Drug Resist. 2019, 12, 2059–2067. [Google Scholar] [CrossRef]
  33. World Health Organization. Antimicrobial Stewardship Programmes in Health-Care Facilities in Low- and Middle-Income Countries. A WHO Practical Toolkit; World Health Organization: Geneva, Switzerland, 2019. [Google Scholar]
  34. von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbroucke, J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Lancet 2007, 370, 1453–1457. [Google Scholar] [CrossRef]
  35. Amponsah, O.K.O.; Courtenay, A.; Ayisi-Boateng, N.K.; Abuelhana, A.; Opoku, D.A.; Blay, L.K.; Abruquah, N.A.; Osafo, A.B.; Danquah, C.B.; Tawiah, P.; et al. Assessing the Impact of Antimicrobial Stewardship Implementation at a District Hospital in Ghana Using a Health Partnership Model. JAC-Antimicrob. Resist. 2023, 5, dlad084. [Google Scholar] [CrossRef]
  36. World Health Organization. The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book; World Health Organization: Geneva, Switzerland, 2022. [Google Scholar]
  37. Phamnguyen, T.J.; Murphy, G.; Hashem, F. Single Centre Observational Study on Antibiotic Prescribing Adherence to Clinical Practice Guidelines for Treatment of Uncomplicated Urinary Tract Infection. Infect. Dis. Health 2019, 24, 75–81. [Google Scholar] [CrossRef] [PubMed]
  38. Sabih, A.; Leslie, S.W. Complicated Urinary Tract Infections; StatPearls Publishing: Petersburg, FA, USA, 2024. [Google Scholar]
  39. Morgan, D.J.; Coffey, K.C. Shorter Courses of Antibiotics for Urinary Tract Infection in Men. JAMA 2021, 326, 309–310. [Google Scholar] [CrossRef] [PubMed]
  40. Germanos, G.J.; Trautner, B.W.; Zoorob, R.J.; Salemi, J.L.; Drekonja, D.; Gupta, K.; Grigoryan, L. No Clinical Benefit to Treating Male Urinary Tract Infection Longer Than Seven Days: An Outpatient Database Study. Open Forum Infect. Dis. 2019, 6, ofz216. [Google Scholar] [CrossRef]
Figure 1. Flowchart depicting empirical antibiotic prescription for outpatients suspected of having uncomplicated UTI and guideline concordance among prescribers at Korle Bu Polyclinic/Family Medicine Department of Ghana during January 2023 to December 2024. 1 Prescription of antibiotic of any class by the treating physician. 2 Prescription of either oral ciprofloxacin or cefuroxime, as recommended in the STGs. 3 Prescription of either oral ciprofloxacin or cefuroxime in at the correct dose, route, frequency, and duration, as recommended in the STGs. Abbreviations: UTI = urinary tract infection; STGs = standard treatment guidelines.
Figure 1. Flowchart depicting empirical antibiotic prescription for outpatients suspected of having uncomplicated UTI and guideline concordance among prescribers at Korle Bu Polyclinic/Family Medicine Department of Ghana during January 2023 to December 2024. 1 Prescription of antibiotic of any class by the treating physician. 2 Prescription of either oral ciprofloxacin or cefuroxime, as recommended in the STGs. 3 Prescription of either oral ciprofloxacin or cefuroxime in at the correct dose, route, frequency, and duration, as recommended in the STGs. Abbreviations: UTI = urinary tract infection; STGs = standard treatment guidelines.
Tropicalmed 10 00259 g001
Table 1. Dissemination of findings and recommendations for improving adherence to guidelines in the management of uncomplicated UTI from the operational research study conducted by Owusu et al. [23] in 2022.
Table 1. Dissemination of findings and recommendations for improving adherence to guidelines in the management of uncomplicated UTI from the operational research study conducted by Owusu et al. [23] in 2022.
Mode of DeliveryTo Whom (Number)WhereWhen
Three-minute lightning PowerPoint presentationMoH stakeholders (32)The national SORT IT module 4 October 2022
Published articleGlobal and national AMS/AMR professional groups (35)Social media platforms: Whatsapp, Facebook, and LinkedInNovember 2022
Twenty-minute technical PowerPoint presentationPolyclinic staff and other medical officers (50+)Polyclinic morning meeting (Online)January 2023
Ten-minute technical PowerPoint presentationMoH stakeholders (30)National SORT IT dissemination programmeJuly 2023
Poster presentationPharmacists from all over Ghana (500+)Annual General Meeting of Pharmacists September 2023
Plain language handoutsPolyclinic core management Team (5)Polyclinic HoD officeDecember, 2022
Pharmacy students and interns (100)Polyclinic pharmacyJanuary 2023
Abbreviations: SORT IT—Structured Operational Research Training IniTiative; HoD—Head of Department; MoH—Ministry of Health; AMS—antimicrobial stewardship; AMR—antimicrobial resistance.
Table 2. List of recommendations from the operational research on compliance with the STGs for prescribing empirical antibiotics in a primary health facility by Owusu et al. [23] in 2022 and the implementation status of these recommendations as of July 2024.
Table 2. List of recommendations from the operational research on compliance with the STGs for prescribing empirical antibiotics in a primary health facility by Owusu et al. [23] in 2022 and the implementation status of these recommendations as of July 2024.
RecommendationAction StatusDetails of Action (When)
Institute an audit feedback system by leveraging the EMR within a comprehensive antimicrobial stewardship programmeFully implementedA clinical audit–feedback system was integrated into the resident training in January 2023.
Clinical audit and feedback on malaria and pneumonia management were implemented in September 2023 and March 2024, respectively. The prescribers were presented with the findings and feedback was provided on ways to improve compliance with the STGs.
The antimicrobial stewardship committee with a dedicated clinical audit and feedback team is yet to be established, although efforts are far advanced.
Determine and address reasons for the poor compliance in this studyPartially implementedThis was performed informally by interviewing the residents and medical officers in February and March 2023. It was discovered that apart from the STGs, other international guidelines are used by prescribers, including the BNF, Medscape, and UpToDate.
Systematic monitoring of compliance with STGs for other diseasesFully implementedMonitoring of compliance with guidelines in severe malaria and pneumonia completed in September 2023 and March 2024, respectively.
Promote similar efforts to assess compliance with STGs across primary care facilities with EMRsPartially implementedOngoing collaborations with 5 other Ghanaian hospitals (Police Hospital, Tema General Hospital, Keta Municipal Hospital, University of Ghana Medical Center, and Cape Coast Teaching Hospital) to determine compliance with guidelines in prescribing for community-acquired pneumonia.
Consider revising the STGs on treatment of uncomplicated UTI based on current evidencePartially implemented The Ministry of Health is currently reviewing the STGs
Abbreviations: EMRs—electronic medical records; HoD—Head of Department; BNF—British National Formulary; STGs—standard treatment guidelines.
Table 3. Comparison of socio-demographic, clinical, and prescriber characteristics of adults with uncomplicated UTI diagnosed in the outpatient department of the Korle Bu Polyclinic/Family Medicine Department of Ghana before (October 2019 to October 2021) and after (January 2024 to December 2024) the operational research conducted in 2022.
Table 3. Comparison of socio-demographic, clinical, and prescriber characteristics of adults with uncomplicated UTI diagnosed in the outpatient department of the Korle Bu Polyclinic/Family Medicine Department of Ghana before (October 2019 to October 2021) and after (January 2024 to December 2024) the operational research conducted in 2022.
CharacteristicsBeforeAfterp Value 4
n(%) 1n(%) 1
Total3717(100)3457
Age in years
18–29757(20.4)730(21.1)0.130
30–44919(24.7)775(22.4)
45–59804(21.6)787(22.8)
≥601237(33.3)1165(33.7)
Gender
Male1064(28.6)974(28.2)0.672
Female2653(71.4)2483(71.8)
NHIS
Yes2920(78.5)2718(78.6)0.473
No797(21.5)739(21.4)
Comorbidities 2
Diabetes mellitus621(16.7)644(18.6)0.016
Hypertension1231(33.1)1327(38.4)<0.001
Routine urine examination
Not done1137(30.5)1138(32.9)0.007
Done2574(69.3)2319(67.1)
Missing6(0.2)
Prescriber sex
Male2084(56.0)1783(51.6)<0.001
Female1623(43.7)1674(48.4)
Missing10(0.3)
Prescriber rank 3
Physician Assistant36(1.0)32(1.0)<0.001
Medical Officer1616(43.5)1466(42.4)
Senior/Principal/Deputy Chief/Chief Medical Officer348(9.4)554(16.0)
Resident/Senior Resident1136(30.6)1103(31.9)
Specialist/Senior Specialist/Consultant469(15.6)302(8.7)
1 Column percentage. 2 Multiple comorbidities are possible. 3 Those joining the service immediately after graduation are designated as medical officers. Based on their years of service, the medical officers progress through the ranks of the senior medical officer, deputy chief medical officer, and chief medical officer. Doctors with postgraduate specialization join as senior residents and progress through the ranks of specialist, senior specialist, and consultant. 4 Chi-square test. UTI—urinary tract infection; NHIS = National Health Insurance Scheme.
Table 4. Compliance with STGs for management of adult patients with uncomplicated UTI diagnosed at the Korle Bu Polyclinic/Family Medicine Department of Ghana before (October 2019 to October 2021) and after (January 2024 to December 2024) the operational research conducted in 2022.
Table 4. Compliance with STGs for management of adult patients with uncomplicated UTI diagnosed at the Korle Bu Polyclinic/Family Medicine Department of Ghana before (October 2019 to October 2021) and after (January 2024 to December 2024) the operational research conducted in 2022.
ParticularsBeforeAfterp Value 2
Nn(%) 1Nn(%) 1
Prescribed any empirical antibiotic37173073(83)34572986(86)<0.001
Prescribed the empirical antibiotic recommended in the STGs 330732714(88)29862719(91)<0.001
Prescribed the empirical antibiotic recommended in the STGs at the correct dose 427142712(~100)27192717(~100)0.996
Prescribed the empirical antibiotic recommended in the STGs for the correct duration 427141848(68)27191977(73)<0.001
Prescribed the empirical antibiotic recommended in the STGs in the correct route 427142712(~100)27192719(100)0.156
Prescribed the empirical antibiotic recommended in the STGs in the correct frequency 427142712(~100)27192718(~100)0.561
Prescribed the empirical antibiotic in line with the STGs 530731847(60)29861975 (66)<0.001
1 Percentage calculated with preceding N as the denominator. 2 p value calculated using chi-squared test. 3 Prescription of either oral ciprofloxacin or cefuroxime as recommended in the STGs among those who were prescribed empirical antibiotics. 4 Dose, duration, and frequency in line with the STGs when either oral ciprofloxacin or cefuroxime was prescribed. 5 Prescription of either oral ciprofloxacin or cefuroxime in the dose, frequency, and duration recommended in the STGs among those who received empirical antibiotics.
Table 5. Distribution of empirical antimicrobials across WHO AWaRe categories prescribed for adults diagnosed with uncomplicated UTI in the outpatient department of the Korle Bu Polyclinic/Family Medicine Department of Ghana before (October 2019 to October 2021) and after (January 2024 to December 2024) the operational research conducted in 2022.
Table 5. Distribution of empirical antimicrobials across WHO AWaRe categories prescribed for adults diagnosed with uncomplicated UTI in the outpatient department of the Korle Bu Polyclinic/Family Medicine Department of Ghana before (October 2019 to October 2021) and after (January 2024 to December 2024) the operational research conducted in 2022.
AntimicrobialsBefore, N = 3378After, N = 3491p Value b
n(%) an(%) a
Access
Total381(11.2)577(16.5)<0.001
Tinidazole119(3.5)121(3.5)0.898
Nitrofurantoin90(2.7)142(4.1)<0.001
Doxycycline88(2.6)157(4.5)<0.001
Amoxicillin/clavulanic acid52(1.5)22(0.6)<0.001
Secnidazole20(0.6)38(1.1)0.025
Metronidazole8(0.2)72(2.0)<0.001
Clindamycin2(0.1)13(0.4)0.005
Amoxicillin1(<0.1)7(0.2)0.038
Sulfamethoxazole/trimethoprim1(<0.1)5(0.1)0.111
Watch
Total2997(88.8)2914(83.5)<0.001
Cefuroxime1831(54.2)1479(42.4) <0.001
Ciprofloxacin1036(30.7)1252(35.9)<0.001
Cefixime38(1.1)86(2.5)<0.001
Ceftriaxone33(1.0)17(0.5)0.017
Levofloxacin31(0.9)18(0.5)0.048
Azithromycin23(0.7)50(1.4)0.002
Cefpodoxime3(0.1)3(0.1)0.968
Clarithromycin2(0.1)9(0.2)0.040
a Column percentage with total number of antibiotics as the denominator. b Chi-squared test. UTI = urinary tract infection; AWaRe = Access, Reserve, and Watch; WHO = World Health Organization.
Table 6. Patient and prescriber characteristics associated with the prescription of empirical antibiotics not in line with the STGs among adults prescribed any empirical antibiotic for uncomplicated UTI in the outpatient department of the Korle Bu Polyclinic/Family Medicine Department of Ghana after (January 2024 to December 2024) the operational research conducted in 2022.
Table 6. Patient and prescriber characteristics associated with the prescription of empirical antibiotics not in line with the STGs among adults prescribed any empirical antibiotic for uncomplicated UTI in the outpatient department of the Korle Bu Polyclinic/Family Medicine Department of Ghana after (January 2024 to December 2024) the operational research conducted in 2022.
CharacteristicsTotalEmpirical Antibiotics not in Line with STGsUnadjusted bAdjusted c
n(%) aPR(95% CI) aPR(95% CI)
Total29861011(33.9)
Age in years
18–29628168(26.8)1 1
30–44660216(32.7)1.2(1.0–1.4)1.1(0.9–1.3)
45–59685252(36.8)1.4(1.2–1.6)1.1(0.9–1.3)
≥601013375(37.0)1.4(1.2–1.6)1.1(0.9–1.3)
Gender
Male844689(81.6)5.4(4.9–6.0)5.4(4.9–6.1)
Female2142322(15.0)1 1
NHIS
Yes2568851(33.1)1 1
No418160(38.3)1.2(1.0–1.3)1.0(0.8–1.1)
Comorbidities d
Diabetes mellitus537181(33.7)1.0(0.9–1.1)1.1(1.0–1.2)
Hypertension1142419(36.7)1.1(1.0–1.3)1.0(0.9–1.1)
Routine urine examination
Done960333(34.7)1.0(0.9–1.2)1.0(1.0–1.1)
Not done2026678(33.5)1 1
Prescriber gender
Male1537523(34.0)1.0(0.9–1.1)1.0
Female1449488(33.7)1 1
Prescriber rank e
Physician Assistant2510(40.0)1.2(0.8–2.0)1.3(0.8–2.1)
Medical Officer1269439(34.6)1.1(0.9–1.2)1.0(0.9–1.1)
Senior/Principal/Deputy Chief/Chief Medical Officer484167(34.5)1.1(0.9–1.2)1.0(0.9–1.1)
Resident/Senior Resident957310(32.4)1 1
Specialist/Snr Specialist/Consultant25185(33.9)1.0(0.9–1.3)1.0(0.9–1.2)
a Row percentage; b log binomial regression; c modified Poisson regression with all the patient and prescriber characteristics included and categories in bold are statistically significant; d not having the specific comorbidity is the reference; e Those joining the service immediately after graduation are designated as medical officers. Based on their years of service, the medical officers progress through the ranks of the senior medical officer, principal medical officer, deputy chief medical officer, and chief medical officer. Doctors with postgraduate specialization join as residents and progress through the ranks of senior residents, specialist, senior specialist, and consultant. UTI = urinary tract infection; STGs = standard treatment guidelines; PR = prevalence ratio; CI = confidence interval; aPR = adjusted prevalence ratio.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Boateng, E.; Owusu, H.; Thekkur, P.; Hedidor, G.K.; Corquaye, O.; Opare-Addo, M.N.A.; Nkansah, F.A.; Vandyck-Sey, P.; Ankrah, D.; Ofei-Palm, C.N.K. Operational Research Improves Compliance with Treatment Guidelines for Empirical Management of Urinary Tract Infection: A Before-and-After Study from a Primary Health Facility in Ghana. Trop. Med. Infect. Dis. 2025, 10, 259. https://doi.org/10.3390/tropicalmed10090259

AMA Style

Boateng E, Owusu H, Thekkur P, Hedidor GK, Corquaye O, Opare-Addo MNA, Nkansah FA, Vandyck-Sey P, Ankrah D, Ofei-Palm CNK. Operational Research Improves Compliance with Treatment Guidelines for Empirical Management of Urinary Tract Infection: A Before-and-After Study from a Primary Health Facility in Ghana. Tropical Medicine and Infectious Disease. 2025; 10(9):259. https://doi.org/10.3390/tropicalmed10090259

Chicago/Turabian Style

Boateng, Elizabeth, Helena Owusu, Pruthu Thekkur, George Kwesi Hedidor, Oksana Corquaye, Mercy N. A. Opare-Addo, Florence Amah Nkansah, Priscilla Vandyck-Sey, Daniel Ankrah, and Charles Nii Kwadee Ofei-Palm. 2025. "Operational Research Improves Compliance with Treatment Guidelines for Empirical Management of Urinary Tract Infection: A Before-and-After Study from a Primary Health Facility in Ghana" Tropical Medicine and Infectious Disease 10, no. 9: 259. https://doi.org/10.3390/tropicalmed10090259

APA Style

Boateng, E., Owusu, H., Thekkur, P., Hedidor, G. K., Corquaye, O., Opare-Addo, M. N. A., Nkansah, F. A., Vandyck-Sey, P., Ankrah, D., & Ofei-Palm, C. N. K. (2025). Operational Research Improves Compliance with Treatment Guidelines for Empirical Management of Urinary Tract Infection: A Before-and-After Study from a Primary Health Facility in Ghana. Tropical Medicine and Infectious Disease, 10(9), 259. https://doi.org/10.3390/tropicalmed10090259

Article Metrics

Back to TopTop